Playlist
Today, on August 21, 2025, the Second International Universal Exhibition-Fair Kids Expo: "All for Children" officially opened in Ashgabat. The event takes place at the Chamber of Commerce and Industry of Turkmenistan and will run through August 23.
The exhibition is organized by the Chamber of Commerce and Industry of Turkmenistan in cooperation with Turkmen Expo. Kids Expo is a unique international platform that brings together business, education, technology, and entertainment — all aimed at child development and family support.
Visitors can enjoy robot sumo battles, children’s fashion shows, creative workshops, a cyber zone with VR and AI labs, sports events, educational games, and a vibrant market of children's goods. Delegations from more than 20 countries are expected to participate.
Kids Expo 2025 continues its mission to foster child development, empower parents, and promote international cooperation in the sphere of childhood. It's more than just an exhibition — it’s a true celebration of learning, innovation, and joy for both children and adults.
American researchers have initiated trials for a new pharmaceutical compound designated as ENV-308, designed to replicate the physiological effects of intensive physical training. Formulated in tablet form, the medication aims to trigger the body's metabolic responses similar to those experienced during exercise.
Scientists at Enveda utilized the Lac-Phe molecule as the core component for this development. Naturally produced by the body during vigorous exertion, this molecule transmits signals to the brain that suppress appetite and signal satiety.
Preclinical trials conducted on animal models demonstrated significant positive results. The tablets effectively reduced hunger levels and facilitated weight loss while entirely preserving existing muscle mass.
Researchers have successfully completed the first phase of clinical trials, confirming the safety of the drug for human use. Future studies will focus on evaluating the compound's impact on metabolism and exploring its potential combination with established therapeutics such as Ozempic.
Blitz